News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Roche’s Tamiflu Gets EU Approval For Use On Children
January 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tamiflu, the anti-influenza drug being stockpiled around the world as a potential defence against bird flu, has received approval to be used for children aged one to twelve in the European Union.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Roche
MORE ON THIS TOPIC
COVID-19
FDA’s own report shows no child deaths definitively caused by COVID vaccination
May 19, 2026
·
3 min read
·
Tristan Manalac
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
May 18, 2026
·
1 min read
·
Tristan Manalac
Government
Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues
May 18, 2026
·
2 min read
·
Tristan Manalac
Opinion
FDA alignment is critical to serving the rare disease community. AI can help
May 18, 2026
·
4 min read
·
Rahul Gupta